記錄引文

Citação APA (7ª ed.)
Wu, X., Wang, D., Wang, J., Huang, Y., Yi, T., Li, G., . . . Su, W. (2026). Fruquintinib plus sintilimab in advanced cervical cancer: An open-label, multicentre, phase 2 study. Nature Portfolio.
Citação do estilo Chicago (17ª ed.)
Wu, Xiaohua, et al. Fruquintinib Plus Sintilimab in Advanced Cervical Cancer: An Open-label, Multicentre, Phase 2 Study. Nature Portfolio, 2026.
Citação MLA (9ª ed.)
Wu, Xiaohua, et al. Fruquintinib Plus Sintilimab in Advanced Cervical Cancer: An Open-label, Multicentre, Phase 2 Study. Nature Portfolio, 2026.
警告:這些引文格式不一定是100%准確.